Your browser doesn't support javascript.
loading
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank.
Afiliación
  • Hardt K; Janssen Research & Development, Beerse, Belgium.
  • Vandebosch A; Janssen Research & Development, Beerse, Belgium.
  • Sadoff J; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Le Gars M; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Truyers C; Janssen Research & Development, Beerse, Belgium.
  • Lowson D; Janssen Research & Development, High Wycombe, UK.
  • Van Dromme I; Janssen Research & Development, Beerse, Belgium.
  • Vingerhoets J; Janssen Research & Development, Beerse, Belgium.
  • Kamphuis T; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Scheper G; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Ruiz-Guiñazú J; Janssen Research & Development, Beerse, Belgium.
  • Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
  • Spinner CD; Technical University of Munich, Munich, Germany.
  • Schuitemaker H; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Van Hoof J; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Douoguih M; Janssen Vaccines & Prevention, Leiden, Netherlands.
  • Struyf F; Janssen Research & Development, Beerse, Belgium. Electronic address: fstruyf@its.jnj.com.
Lancet Infect Dis ; 22(12): 1703-1715, 2022 12.
Article en En | MEDLINE | ID: mdl-36113538
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adolescent / Adult / Humans Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Bélgica